Xinjiang Baihuacun Co Ltd (600721) - Net Assets

Latest as of September 2025: CN¥793.82 Million CNY ≈ $116.16 Million USD

Based on the latest financial reports, Xinjiang Baihuacun Co Ltd (600721) has net assets worth CN¥793.82 Million CNY (≈ $116.16 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥1.12 Billion ≈ $163.99 Million USD) and total liabilities (CN¥326.82 Million ≈ $47.82 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 600721 financial resilience to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥793.82 Million
% of Total Assets 70.84%
Annual Growth Rate 11.51%
5-Year Change 21.54%
10-Year Change 66.68%
Growth Volatility 319.95

Xinjiang Baihuacun Co Ltd - Net Assets Trend (1994–2024)

This chart illustrates how Xinjiang Baihuacun Co Ltd's net assets have evolved over time, based on quarterly financial data. Also explore Xinjiang Baihuacun Co Ltd balance sheet assets for the complete picture of this company's asset base.

Annual Net Assets for Xinjiang Baihuacun Co Ltd (1994–2024)

The table below shows the annual net assets of Xinjiang Baihuacun Co Ltd from 1994 to 2024. For live valuation and market cap data, see 600721 market cap overview.

Year Net Assets Change
2024-12-31 CN¥758.58 Million
≈ $111.00 Million
+7.35%
2023-12-31 CN¥706.62 Million
≈ $103.40 Million
+5.94%
2022-12-31 CN¥667.02 Million
≈ $97.61 Million
-2.80%
2021-12-31 CN¥686.25 Million
≈ $100.42 Million
+9.95%
2020-12-31 CN¥624.16 Million
≈ $91.33 Million
-34.62%
2019-12-31 CN¥954.70 Million
≈ $139.70 Million
+3.82%
2018-12-31 CN¥919.58 Million
≈ $134.56 Million
-46.94%
2017-12-31 CN¥1.73 Billion
≈ $253.60 Million
-24.60%
2016-12-31 CN¥2.30 Billion
≈ $336.33 Million
+405.03%
2015-12-31 CN¥455.10 Million
≈ $66.60 Million
-54.37%
2014-12-31 CN¥997.28 Million
≈ $145.93 Million
-26.24%
2013-12-31 CN¥1.35 Billion
≈ $197.86 Million
+22.44%
2012-12-31 CN¥1.10 Billion
≈ $161.59 Million
+0.59%
2011-12-31 CN¥1.10 Billion
≈ $160.64 Million
+4.65%
2010-12-31 CN¥1.05 Billion
≈ $153.51 Million
+190.10%
2009-12-31 CN¥361.61 Million
≈ $52.92 Million
+5.03%
2008-12-31 CN¥344.28 Million
≈ $50.38 Million
+2.04%
2007-12-31 CN¥337.41 Million
≈ $49.37 Million
+1632.46%
2006-12-31 CN¥19.48 Million
≈ $2.85 Million
+652.72%
2005-12-31 CN¥2.59 Million
≈ $378.62K
-98.82%
2004-12-31 CN¥218.65 Million
≈ $32.00 Million
-4.90%
2003-12-31 CN¥229.91 Million
≈ $33.64 Million
+28.61%
2002-12-31 CN¥178.77 Million
≈ $26.16 Million
+45.72%
2001-12-31 CN¥122.68 Million
≈ $17.95 Million
-5.93%
2000-12-31 CN¥130.41 Million
≈ $19.08 Million
-41.13%
1999-12-31 CN¥221.52 Million
≈ $32.41 Million
-18.93%
1998-12-31 CN¥273.24 Million
≈ $39.98 Million
+34.19%
1997-12-31 CN¥203.63 Million
≈ $29.80 Million
+4.31%
1996-12-31 CN¥195.21 Million
≈ $28.57 Million
+220.96%
1995-12-31 CN¥60.82 Million
≈ $8.90 Million
+110.42%
1994-12-31 CN¥28.91 Million
≈ $4.23 Million
--

Equity Component Analysis

This analysis shows how different components contribute to Xinjiang Baihuacun Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 190350774000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock CN¥384.03 Million 50.63%
Other Comprehensive Income CN¥74.26 Million 9.79%
Other Components CN¥2.20 Billion 290.52%
Total Equity CN¥758.58 Million 100.00%

Xinjiang Baihuacun Co Ltd Competitors by Market Cap

The table below lists competitors of Xinjiang Baihuacun Co Ltd ranked by their market capitalization.

Company Market Cap
Spin Master Corp
TO:TOY
$474.38 Million
ADC Therapeutics SA
NYSE:ADCT
$474.45 Million
Hunan Creator Information Technologies Co Ltd Class A
SHE:300730
$474.60 Million
Xinjiang Sayram Modern Agriculture Co Ltd
SHG:600540
$474.71 Million
Wilson Bayly Holmes Ovcon Ltd
JSE:WBO
$474.21 Million
Teladan Prima Agro PT Tbk
JK:TLDN
$474.13 Million
Miwon Commerci
KO:002840
$473.99 Million
Tat Techno
NASDAQ:TATT
$473.86 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Xinjiang Baihuacun Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 706,615,374 to 758,581,718, a change of 51,966,344 (7.4%).
  • Net income of 41,479,043 contributed positively to equity growth.
  • Other comprehensive income decreased equity by 1,165,849.
  • Other factors increased equity by 11,653,150.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income CN¥41.48 Million +5.47%
Other Comprehensive Income CN¥-1.17 Million -0.15%
Other Changes CN¥11.65 Million +1.54%
Total Change CN¥- 7.35%

Book Value vs Market Value Analysis

This analysis compares Xinjiang Baihuacun Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 4.26x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 37.46x to 4.26x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1994-12-31 CN¥0.23 CN¥8.43 x
1995-12-31 CN¥0.53 CN¥8.43 x
1996-12-31 CN¥1.91 CN¥8.43 x
1997-12-31 CN¥2.07 CN¥8.43 x
1998-12-31 CN¥2.77 CN¥8.43 x
1999-12-31 CN¥2.26 CN¥8.43 x
2000-12-31 CN¥1.34 CN¥8.43 x
2001-12-31 CN¥1.26 CN¥8.43 x
2002-12-31 CN¥1.30 CN¥8.43 x
2003-12-31 CN¥1.49 CN¥8.43 x
2004-12-31 CN¥1.52 CN¥8.43 x
2005-12-31 CN¥0.05 CN¥8.43 x
2006-12-31 CN¥0.16 CN¥8.43 x
2007-12-31 CN¥2.63 CN¥8.43 x
2008-12-31 CN¥1.80 CN¥8.43 x
2009-12-31 CN¥1.92 CN¥8.43 x
2010-12-31 CN¥5.27 CN¥8.43 x
2011-12-31 CN¥3.44 CN¥8.43 x
2012-12-31 CN¥3.50 CN¥8.43 x
2013-12-31 CN¥3.64 CN¥8.43 x
2014-12-31 CN¥2.97 CN¥8.43 x
2015-12-31 CN¥1.33 CN¥8.43 x
2016-12-31 CN¥8.11 CN¥8.43 x
2017-12-31 CN¥4.30 CN¥8.43 x
2018-12-31 CN¥2.28 CN¥8.43 x
2019-12-31 CN¥2.39 CN¥8.43 x
2020-12-31 CN¥1.59 CN¥8.43 x
2021-12-31 CN¥1.82 CN¥8.43 x
2022-12-31 CN¥1.78 CN¥8.43 x
2023-12-31 CN¥1.86 CN¥8.43 x
2024-12-31 CN¥1.98 CN¥8.43 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Xinjiang Baihuacun Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 5.47%
  • The company has moderate efficiency in generating returns from equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 10.75%
  • • Asset Turnover: 0.35x
  • • Equity Multiplier: 1.47x
  • Recent ROE (5.47%) is above the historical average (-93.01%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1994 32.79% 8.05% 0.84x 4.84x CN¥4.86 Million
1995 25.31% 9.08% 0.77x 3.61x CN¥7.65 Million
1996 10.09% 8.48% 0.46x 2.57x CN¥160.52K
1997 7.64% 10.28% 0.37x 2.02x CN¥-4.63 Million
1998 -7.60% -17.40% 0.24x 1.82x CN¥-46.28 Million
1999 -18.61% -37.21% 0.25x 2.00x CN¥-61.24 Million
2000 -68.72% -94.14% 0.27x 2.73x CN¥-99.88 Million
2001 3.94% 12.04% 0.12x 2.62x CN¥-7.25 Million
2002 2.80% 1.52% 0.38x 4.77x CN¥-8.86 Million
2003 11.58% 4.82% 0.45x 5.32x CN¥2.24 Million
2004 -6.18% -7.47% 0.20x 4.06x CN¥-23.34 Million
2005 -2604.88% -262.30% 0.16x 62.46x CN¥-121.58 Million
2006 7.75% 2.43% 0.20x 15.69x CN¥-371.70K
2007 2.26% 14.99% 0.05x 2.98x CN¥-19.27 Million
2008 2.62% 17.15% 0.05x 3.18x CN¥-18.87 Million
2009 6.26% 26.80% 0.07x 3.51x CN¥-10.21 Million
2010 4.78% 5.89% 0.17x 4.75x CN¥-44.74 Million
2011 8.18% 6.24% 0.27x 4.77x CN¥-16.83 Million
2012 2.17% 1.83% 0.25x 4.69x CN¥-73.69 Million
2013 0.31% 0.25% 0.27x 4.55x CN¥-94.61 Million
2014 -31.61% -21.07% 0.27x 5.64x CN¥-307.54 Million
2015 -121.78% -50.20% 0.20x 12.19x CN¥-439.32 Million
2016 6.09% 18.69% 0.27x 1.22x CN¥-89.43 Million
2017 -32.77% -134.47% 0.21x 1.18x CN¥-736.27 Million
2018 -88.42% -192.72% 0.34x 1.37x CN¥-899.23 Million
2019 3.60% 13.12% 0.20x 1.35x CN¥-61.08 Million
2020 -51.64% -378.28% 0.09x 1.57x CN¥-381.69 Million
2021 8.78% 21.26% 0.29x 1.44x CN¥-8.30 Million
2022 -5.21% -9.93% 0.35x 1.50x CN¥-101.43 Million
2023 1.84% 3.51% 0.35x 1.50x CN¥-57.69 Million
2024 5.47% 10.75% 0.35x 1.47x CN¥-34.38 Million

Industry Comparison

This section compares Xinjiang Baihuacun Co Ltd's net assets metrics with peer companies in the Restaurants industry.

Industry Context

  • Industry: Restaurants
  • Average net assets among peers: $1,577,201,283
  • Average return on equity (ROE) among peers: -19.07%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Xinjiang Baihuacun Co Ltd (600721) CN¥793.82 Million 32.79% 0.41x $474.37 Million
XiAn Catering Co Ltd (000721) $706.92 Million 1.56% 0.51x $637.42 Million
China Quanjude Group Co Ltd (002186) $869.59 Million 3.92% 0.72x $480.11 Million
Cloud Live Technology Group Co Ltd (002306) $602.19 Million -93.72% 1.79x $304.18 Million
Guangzhou Restaurants Group Co (603043) $4.13 Billion 11.96% 0.57x $1.29 Billion

About Xinjiang Baihuacun Co Ltd

SHG:600721 China Restaurants
Market Cap
$474.37 Million
CN¥3.24 Billion CNY
Market Cap Rank
#12796 Global
#4003 in China
Share Price
CN¥8.43
Change (1 day)
-1.06%
52-Week Range
CN¥7.01 - CN¥12.24
All Time High
CN¥20.70
About

Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd engages in pharmaceutical research and development, clinical trials, biomedicine, commercial properties, and other businesses. It also offers comprehensive contract research organization (CRO) solutions, including one-stop, full-process services for drug R&D, such as Phase I to IV clinical trials, bioequivalence and pharmacokinetics testing, medical scienc… Read more